Take Ltd. Share Price

Overview

Take Ltd. share price is currently ₹11.58, down by - ₹0.89 (7.14%) from its previous closing price of ₹12.47. The share price has declined -14.03% over the past month and gained 11.78% over the past year. The stock's 52-week low and high are ₹11.58 and ₹49.41, respectively. Take Ltd. has a market capitalisation of ₹ 190.00 Cr. The share price was last updated on 05 Oct 2026, 03:29 PM IST.

Take Ltd.
Take Ltd.
TAKE
 ₹0.00
- ₹0.89
7.14%
IT
 ₹0.00(%)1D

Updated: 05 Oct 2026, 03:29:52 pm IST

Market Data

Open Price

 ₹12.24

Prev. Close

 ₹12.47
 ₹11.58

Day Low

 ₹12.50

Day High

 ₹11.58

52 Week Low

 ₹49.41

52 Week High

ITIT - Software
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

13.31

Sector PE

19.63

PB Ratio

8.27

Sector PB

4.43

EPS

0.87

Dividend Yield

0.00

Today's Volume

1.015 M

5 Day Avg. Volume

441.835 K

PEG Ratio

0.10

Market Cap.

₹ 190.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Take Ltd. 👋

Take Limited, formerly Take Solutions Limited, is an India-based contract research organization (CRO), which is engaged in supporting pharma, biotech and devices companies. The Company offers clients a combination of full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry network forums. Its digital healthcare services include medical decision-making (artificial intelligence and machine learning), and cloud adoption & mobility. Its global roster of clients includes large and small biopharmaceutical and device companies, United States federal agencies like the Centers for Disease Control and Prevention (CDC) and the United States Department of Defense (DoD), as well as generics manufacturers. The Company's subsidiary is Ecron Acunova Limited.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
RAJIV GUPTA (SEBI RA)

RAJIV GUPTA (SEBI RA)

21 Feb • 5:35 PM · SEBI-Registered Analyst

Taps Anthropic to Accelerate AI Dominance - Take Solutions Ltd

Code BSE: 532890 NSE:

TAKE
TAKE Solutions Taps Anthropic to Accelerate AI Dominance in $370B Healthcare Sector Take Solutions Limited, today announced the integration of advanced artificial intelligence capabilities powered by Antropic’s Claude. This strategic technology adoption marks a significant milestone in Take Solution’s ongoing mission to build scalable, intelligent, and preventive healthcare platforms designed to improve outcomes, enhance efficiency, and enable data-driven healthcare delivery. The integration of Antropic’s Claude advanced AI capabilities will strengthen Take Solution’s upcoming platforms, including its AI-driven Preventive Healthcare Platform, One Minute Clinic, and its Unified AI Marketplace. These platforms are being designed to transition healthcare from a reactive treatment model to a predictive and preventive care ecosystem.

See More

Frequently Asked Questions

What is the share price of Take Ltd.?

What is the market cap of Take Ltd.?

Should I buy Take Ltd. stock now?

What is the 52 week high and low of Take Ltd.?

Is the Take Ltd. stock good to buy?

Is Take Ltd. a good buy for the long term?

Is Take Ltd. overvalued or undervalued?

What is the PE and PB ratio of Take Ltd.?

Start Now